KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Recursion Pharmaceuticals (RXRX) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for Recursion Pharmaceuticals (RXRX) over the last 5 years, with Sep 2025 value amounting to 0.03.

  • Recursion Pharmaceuticals' Asset Utilization Ratio fell 62.73% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year decrease of 62.73%. This contributed to the annual value of 0.06 for FY2024, which is 14.92% down from last year.
  • Latest data reveals that Recursion Pharmaceuticals reported Asset Utilization Ratio of 0.03 as of Q3 2025, which was down 34.73% from 0.05 recorded in Q2 2025.
  • Recursion Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.09 during Q3 2024, with a 5-year trough of 0.02 in Q3 2021.
  • Over the past 3 years, Recursion Pharmaceuticals' median Asset Utilization Ratio value was 0.07 (recorded in 2023), while the average stood at 0.06.
  • In the last 5 years, Recursion Pharmaceuticals' Asset Utilization Ratio surged by 278.38% in 2022 and then slumped by 62.73% in 2025.
  • Recursion Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.02 in 2021, then spiked by 278.38% to 0.06 in 2022, then rose by 14.34% to 0.07 in 2023, then fell by 22.05% to 0.05 in 2024, then slumped by 62.73% to 0.03 in 2025.
  • Its last three reported values are 0.03 in Q3 2025, 0.05 for Q2 2025, and 0.04 during Q1 2025.